US FDA globalisation bill awaits attention
This article was originally published in Clinica
Executive Summary
A bill that would create an inspectorate within the US FDA dedicated to inspecting foreign facilities is gathering co-sponsors but is still waiting for attention from the House energy and commerce committee.
You may also be interested in...
US: The sun shines in on industry-doctor relationships
The US healthcare reform proposals signed into law on 23 March include requirements on medical device companies to reveal payments or gifts they make to doctors. Peter Rixon takes a closer look at what the reforms’ “sunshine” provisions actually mean
Global regulators/industry to gather in US and Germany to talk device regulation
Compliance, approvals, inspections and many other burning issues will be on the agenda of a US conference that takes place in the coming weeks.
Global regulators and industry execs to gather in US and Germany to talk device regulation
Compliance, approvals, inspections and many other burning issues will be on the agenda of a US conference that takes place in early May.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: